Treatment can lessen severity of early Alzheimer's disease

A new drug can reduce cognitive and functional decline in people with early Alzheimer’s disease. Neurologist Tinatin Chabrashvili , MD, PhD, explains what to expect from the drug, lecanemab, which is given by infusion at Upstate University Hospital. Chabrashvili is a professor of neurology and the director of Upstate’s Neurodegenerative Disorders Center.
“The Informed Patient” is a podcast that covers health, science and medicine, featuring experts from Central New York’s only academic medical center. Upstate Medical University has four colleges (Medicine, Nursing, Health Professions and Graduate Studies); a robust research enterprise; and an extensive clinical health care system that extends way beyond Syracuse.
For more information, please visit: www.upstate.ed...